Related Experiment Videos
Hodgkin disease, nodular sclerosis type. Implications of histologic subclassification
J A Ferry1, R M Linggood, K M Convery
1Department of Pathology, Massachusetts General Hospital, Boston 02114.
Cancer
|January 15, 1993
Summary
Histologic grade is a crucial factor in predicting outcomes for nodular sclerosis Hodgkin disease (HDNS). Patients with low-grade (NSI) HDNS have significantly better survival and salvage rates than those with high-grade (NSII) disease.
Area of Science:
- Oncology
- Pathology
Background:
- The prognostic significance of cellular composition in nodular sclerosis Hodgkin disease (HDNS) remains debated.
- Accurate prognostic indicators are essential for tailoring treatment strategies in HDNS.
Purpose of the Study:
- To investigate the prognostic value of histologic subclassification in nodular sclerosis Hodgkin disease (HDNS).
- To determine the impact of histologic grade on patient survival and relapse rates.
Main Methods:
- Retrospective analysis of tumors from 79 patients with HDNS.
- Classification of cases into low-grade (NSI) and high-grade (NSII) based on British National Lymphoma Investigation criteria.
- Median follow-up of 9.3 years, with analysis of survival, relapse, and salvage rates.
Main Results:
- High-grade (NSII) HDNS was associated with significantly shorter overall survival (P = 0.0001).
- Histologic grade was the strongest predictor of overall survival (hazard ratio = 10.19) and disease-free survival after relapse (hazard ratio = 26.5).
- Five-year survival was 100% for NSI versus 75% for NSII; five-year disease-free survival after relapse was 94% for NSI versus 11% for NSII.
Conclusions:
- Histologic subclassification of HDNS into NSI and NSII is clinically relevant.
- Patients with NSI disease experience more successful salvage and longer survival, particularly after relapse.
- Consideration of histologic subtype is important for optimizing therapy planning in HDNS.